Drug-Target Information | ||||||||
---|---|---|---|---|---|---|---|---|
Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
clobazam | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Epilepsy[MeSHID:D004827] Lennox-Gastaut syndrome[MeSHID:D065768] Seizures[MeSHID:D012640] |
0.22 | approved,illicit | positive allosteric modulator,positive modulator |
clobazam | gaba(a) receptor benzodiazepine binding site | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Epilepsy[MeSHID:D004827] Lennox-Gastaut syndrome[MeSHID:D065768] Seizures[MeSHID:D012640] |
0.22 | approved,illicit | ligand,positive modulator |
clobazam | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Epilepsy[MeSHID:D004827] Lennox-Gastaut syndrome[MeSHID:D065768] Seizures[MeSHID:D012640] |
0.22 | approved,illicit | positive allosteric modulator |
clobazam | gaba(a) receptor benzodiazepine binding site | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Epilepsy[MeSHID:D004827] Lennox-Gastaut syndrome[MeSHID:D065768] Seizures[MeSHID:D012640] |
0.22 | approved,illicit | ligand |
clobazam | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Epilepsy[MeSHID:D004827] Lennox-Gastaut syndrome[MeSHID:D065768] Seizures[MeSHID:D012640] |
0.11 | approved,illicit | positive allosteric modulator,positive modulator |
clobazam | gaba(a) receptor benzodiazepine binding site | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Epilepsy[MeSHID:D004827] Lennox-Gastaut syndrome[MeSHID:D065768] Seizures[MeSHID:D012640] |
0.11 | approved,illicit | ligand |
clobazam | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Epilepsy[MeSHID:D004827] Lennox-Gastaut syndrome[MeSHID:D065768] Seizures[MeSHID:D012640] |
0.11 | approved,illicit | positive allosteric modulator |
clobazam | gaba(a) receptor benzodiazepine binding site | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Epilepsy[MeSHID:D004827] Lennox-Gastaut syndrome[MeSHID:D065768] Seizures[MeSHID:D012640] |
0.11 | approved,illicit | ligand,positive modulator |
clobazam | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Epilepsy[MeSHID:D004827] Lennox-Gastaut syndrome[MeSHID:D065768] Seizures[MeSHID:D012640] |
0.11 | approved,illicit | positive allosteric modulator |
clobazam | gaba(a) receptor benzodiazepine binding site | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Epilepsy[MeSHID:D004827] Lennox-Gastaut syndrome[MeSHID:D065768] Seizures[MeSHID:D012640] |
0.11 | approved,illicit | ligand |
clobazam | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Epilepsy[MeSHID:D004827] Lennox-Gastaut syndrome[MeSHID:D065768] Seizures[MeSHID:D012640] |
0.11 | approved,illicit | positive allosteric modulator,positive modulator |
clobazam | gaba(a) receptor benzodiazepine binding site | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Epilepsy[MeSHID:D004827] Lennox-Gastaut syndrome[MeSHID:D065768] Seizures[MeSHID:D012640] |
0.11 | approved,illicit | ligand,positive modulator |
clobazam | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Epilepsy[MeSHID:D004827] Lennox-Gastaut syndrome[MeSHID:D065768] Seizures[MeSHID:D012640] |
0.12 | approved,illicit | positive allosteric modulator,positive modulator |
clobazam | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Epilepsy[MeSHID:D004827] Lennox-Gastaut syndrome[MeSHID:D065768] Seizures[MeSHID:D012640] |
0.12 | approved,illicit | positive allosteric modulator |
clobazam | gaba(a) receptor benzodiazepine binding site | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Epilepsy[MeSHID:D004827] Lennox-Gastaut syndrome[MeSHID:D065768] Seizures[MeSHID:D012640] |
0.11 | approved,illicit | ligand |
clobazam | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Epilepsy[MeSHID:D004827] Lennox-Gastaut syndrome[MeSHID:D065768] Seizures[MeSHID:D012640] |
0.11 | approved,illicit | positive allosteric modulator |
clobazam | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Epilepsy[MeSHID:D004827] Lennox-Gastaut syndrome[MeSHID:D065768] Seizures[MeSHID:D012640] |
0.11 | approved,illicit | positive allosteric modulator,positive modulator |
clobazam | gaba(a) receptor benzodiazepine binding site | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Epilepsy[MeSHID:D004827] Lennox-Gastaut syndrome[MeSHID:D065768] Seizures[MeSHID:D012640] |
0.11 | approved,illicit | ligand,positive modulator |
clobazam | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Epilepsy[MeSHID:D004827] Lennox-Gastaut syndrome[MeSHID:D065768] Seizures[MeSHID:D012640] |
0.12 | approved,illicit | positive allosteric modulator,positive modulator |
clobazam | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Epilepsy[MeSHID:D004827] Lennox-Gastaut syndrome[MeSHID:D065768] Seizures[MeSHID:D012640] |
0.12 | approved,illicit | positive allosteric modulator |
clobazam | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Epilepsy[MeSHID:D004827] Lennox-Gastaut syndrome[MeSHID:D065768] Seizures[MeSHID:D012640] |
0.14 | approved,illicit | positive allosteric modulator |
clobazam | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Epilepsy[MeSHID:D004827] Lennox-Gastaut syndrome[MeSHID:D065768] Seizures[MeSHID:D012640] |
0.14 | approved,illicit | positive allosteric modulator,positive modulator |
clobazam | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Epilepsy[MeSHID:D004827] Lennox-Gastaut syndrome[MeSHID:D065768] Seizures[MeSHID:D012640] |
0.13 | approved,illicit | positive allosteric modulator |
clobazam | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Epilepsy[MeSHID:D004827] Lennox-Gastaut syndrome[MeSHID:D065768] Seizures[MeSHID:D012640] |
0.13 | approved,illicit | positive allosteric modulator,positive modulator |
clobazam | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Epilepsy[MeSHID:D004827] Lennox-Gastaut syndrome[MeSHID:D065768] Seizures[MeSHID:D012640] |
0.14 | approved,illicit | positive allosteric modulator,positive modulator |
clobazam | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Epilepsy[MeSHID:D004827] Lennox-Gastaut syndrome[MeSHID:D065768] Seizures[MeSHID:D012640] |
0.14 | approved,illicit | positive allosteric modulator |
clobazam | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Epilepsy[MeSHID:D004827] Lennox-Gastaut syndrome[MeSHID:D065768] Seizures[MeSHID:D012640] |
0.15 | approved,illicit | positive allosteric modulator |
clobazam | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Epilepsy[MeSHID:D004827] Lennox-Gastaut syndrome[MeSHID:D065768] Seizures[MeSHID:D012640] |
0.15 | approved,illicit | positive allosteric modulator,positive modulator |
clobazam | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Epilepsy[MeSHID:D004827] Lennox-Gastaut syndrome[MeSHID:D065768] Seizures[MeSHID:D012640] |
0.15 | approved,illicit | positive allosteric modulator |
clobazam | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Epilepsy[MeSHID:D004827] Lennox-Gastaut syndrome[MeSHID:D065768] Seizures[MeSHID:D012640] |
0.15 | approved,illicit | positive allosteric modulator,positive modulator |
clobazam | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Epilepsy[MeSHID:D004827] Lennox-Gastaut syndrome[MeSHID:D065768] Seizures[MeSHID:D012640] |
0.14 | approved,illicit | positive allosteric modulator,positive modulator |
clobazam | gaba(a) receptor benzodiazepine binding site | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Epilepsy[MeSHID:D004827] Lennox-Gastaut syndrome[MeSHID:D065768] Seizures[MeSHID:D012640] |
0.14 | approved,illicit | ligand |
clobazam | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Epilepsy[MeSHID:D004827] Lennox-Gastaut syndrome[MeSHID:D065768] Seizures[MeSHID:D012640] |
0.14 | approved,illicit | positive allosteric modulator |
clobazam | gaba(a) receptor benzodiazepine binding site | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Epilepsy[MeSHID:D004827] Lennox-Gastaut syndrome[MeSHID:D065768] Seizures[MeSHID:D012640] |
0.14 | approved,illicit | ligand,positive modulator |
clobazam | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Epilepsy[MeSHID:D004827] Lennox-Gastaut syndrome[MeSHID:D065768] Seizures[MeSHID:D012640] |
0.09 | approved,illicit | positive allosteric modulator,positive modulator |
clobazam | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Epilepsy[MeSHID:D004827] Lennox-Gastaut syndrome[MeSHID:D065768] Seizures[MeSHID:D012640] |
0.09 | approved,illicit | positive allosteric modulator |
clobazam | gaba(a) receptor benzodiazepine binding site | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Epilepsy[MeSHID:D004827] Lennox-Gastaut syndrome[MeSHID:D065768] Seizures[MeSHID:D012640] |
0.09 | approved,illicit | ligand |
clobazam | gaba(a) receptor benzodiazepine binding site | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Epilepsy[MeSHID:D004827] Lennox-Gastaut syndrome[MeSHID:D065768] Seizures[MeSHID:D012640] |
0.09 | approved,illicit | ligand,positive modulator |
clobazam | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Epilepsy[MeSHID:D004827] Lennox-Gastaut syndrome[MeSHID:D065768] Seizures[MeSHID:D012640] |
0.12 | approved,illicit | positive allosteric modulator |
clobazam | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Epilepsy[MeSHID:D004827] Lennox-Gastaut syndrome[MeSHID:D065768] Seizures[MeSHID:D012640] |
0.12 | approved,illicit | positive allosteric modulator,positive modulator |
clobazam | gaba(a) receptor benzodiazepine binding site | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Epilepsy[MeSHID:D004827] Lennox-Gastaut syndrome[MeSHID:D065768] Seizures[MeSHID:D012640] |
0.12 | approved,illicit | ligand,positive modulator |
clobazam | gaba(a) receptor benzodiazepine binding site | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Epilepsy[MeSHID:D004827] Lennox-Gastaut syndrome[MeSHID:D065768] Seizures[MeSHID:D012640] |
0.12 | approved,illicit | ligand |
clobazam | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Epilepsy[MeSHID:D004827] Lennox-Gastaut syndrome[MeSHID:D065768] Seizures[MeSHID:D012640] |
0.15 | approved,illicit | positive allosteric modulator,positive modulator |
clobazam | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Epilepsy[MeSHID:D004827] Lennox-Gastaut syndrome[MeSHID:D065768] Seizures[MeSHID:D012640] |
0.15 | approved,illicit | positive allosteric modulator |
clobazam | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Epilepsy[MeSHID:D004827] Lennox-Gastaut syndrome[MeSHID:D065768] Seizures[MeSHID:D012640] |
0.16 | approved,illicit | positive allosteric modulator,positive modulator |
clobazam | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Epilepsy[MeSHID:D004827] Lennox-Gastaut syndrome[MeSHID:D065768] Seizures[MeSHID:D012640] |
0.16 | approved,illicit | positive allosteric modulator |
click here to return to the previous page |